Skip to main content

Table 1 Baseline characteristics

From: “As du Coeur” study: a randomized controlled trial on quality of life impact and cost effectiveness of a physical activity program in patients with cardiovascular disease

 

Progressively autonomous group (n = 22)

Supervised group

(n = 23)

p

Age, mean ± SD

62.5 ± 10.7

63.5 ± 8.1

0.64

Sex, n (%)

  

0.58

Male

21 (95.5)

21 (91.3)

Female

1 (4.5)

2 (8.7)

Weight, kg ± SD

82.4 ± 13.7

86.8 ± 12.3

0.27

BMI, kg/m2 ± SD

27.1 ± 4.0

29.5 ± 4.0

0.07

AC, cm ± SD

103.5 ± 12.3

106.0 ± 8.7

0.45

EQ5D, mean ± SD

0.828 ± 0.181

0.791 ± 0.161

0.48

6MWT distance, meters ±SD

600.8 ± 84.2

524.0 ± 88.1

0.0064

NYHA, n (%)

 I

11 (52.4)

6 (27.3)

0.32

 II

7 (33.3)

11 (50.0)

 III

3 (14.3)

4 (18.2)

 IV

1 (4.5)

Past medical history, n (%)

 Diabetes

4 (18.2)

3 (14.3)

0.73

 Hypertension

6 (27.3)

6 (26.1)

0.79

 Hyperlipidemia

16 (72.7)

15 (65.2)

0.59

 Moderate heart failure

1 (4.5)

7 (33.3)

0.0212

 Myocardial infarction

5 (22.7)

9 (40.9)

0.19

Revascularization, n (%)

 Angioplasty

15 (68.2)

13 (56.5)

0.42

 CABG

3 (13.6)

4 (19.0)

0.70

Cardiac function, n (%)

 LVEF < 50%

1 (4.8)

3 (14.3)

0.13

 LVEF > 50%

20 (95.2)

18 (85.7)

 Current smokers, n (%)

4 (18.2)

3 (14.3)

0.73

Drugs, n (%)

 Antiplatelet drugs

19 (86.4)

16 (69.6)

0.17

 Anticoagulants

4 (19.0)

0.0485

 Beta-blockers

11 (50.0)

11 (47.8)

0.88

  1. Abbreviations: AC Abdominal circumference, BMI Body Mass Index, CABG Coronary artery bypass graft, LVEF Left ventricular ejection fraction, 6MWT Six-minute walk test, SD Standard deviation